The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Senna W M LammersHannah ThurischIngeborg J H VriensMarissa MeegdesSanne M E EngelenFrans L G ErdkampM Wouter DercksenBirgit E P J VriensKirsten N A AalderingManon J A E PepelsLinda M H van de WinkelNatascha A J B PetersJolien TolJoan B HeijnsAgnes J van de WouwNathalie J A TeeuwenSandra M E GeurtsVivianne C G Tjan-HeijnenPublished in: Breast cancer research and treatment (2023)
In this study among 1456 patients with HR+/HER2- ABC, overweight and obesity were prevalent, whereas underweight was uncommon. When compared with normal weight, overweight and obesity were not associated with either OS or PFS. However, underweight seemed to be an adverse prognostic factor for OS.